FSK vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

FSK

25.1
AI Score
VS
CNS Wins

CNS

43.0
AI Score

Investment Advisor Scores

FSK

25score
Recommendation
AVOID NEW MONEY

CNS

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FSK CNS Winner
Forward P/E 8.3963 18.5874 FSK
PEG Ratio 3.2724 1.3563 CNS
Revenue Growth -27.1% 11.1% CNS
Earnings Growth 33.8% 0.0% FSK
Tradestie Score 25.1/100 43.0/100 CNS
Profit Margin -28.5% 28.2% CNS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CNS

Relative Price Performance (Last 90 Days)

FSK 1M: +9.2% · 3M: -2.4% CNS 1M: +3.4% · 3M: -14.4%

Current Technical Phase

FSK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 59.7 · Price: $11.72

CNS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.2%) with fading momentum, RSI 46

RSI (14): 46.1 · Price: $71.35

Fundamentals Snapshot

Metric FSK CNS
Market Cap — —
Forward P/E 7.9 19.3
Trailing P/E — 22.0
Revenue (TTM) — —
Revenue Growth -0.3% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.7% 0.3%
EPS -1.86 3.25
Dividend Yield 0.00% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.